P3 Health Partners Inc.
PIII Nasdaq· Services-Health Services
Last close · Oct 23, 2026
$4.14
KIRA · Stoqly’s AI analyst, in plain words
- P3 Health Partners Inc. had $1.5B of revenue in fiscal 2024, down 2.8% on the year before. Over five years, revenue changed +24.3% a year on average.
- Its operating margin was −18.5%, up 2.8 pts: of every 100 in sales, about −19 is left after running the business.
- P3 Health Partners Inc. lost $148M in fiscal 2024.
- P3 Health Partners Inc. owes $248M more than it holds in cash.
Market cap
$13.9M
P/E
—
Revenue
$1.5B
Net income
−$148M
Free cash flow
—
Operating margin
−18.5%
P3 Health Partners Inc. in 30 seconds · fiscal 2024
Are sales growing?
−2.8%
No. Sales fell 2.8% last year.
Does it make a profit?
−10.1%
No. It lost money last year.
How healthy are the accounts?
2 / 8
Weak. It passes 2 of 8 health tests.
How is the share priced?
—
No P/E: it made no profit over the last four quarters.
What P3 Health Partners Inc. does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Mar 26, 2026
- Legal name
- P3 Health Partners Inc.
- CIK
- 0001832511
P3 Health Partners Inc. · PIII
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY19 | FY21 | FY22 | FY23 | FY24 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $491M | — | $1.3B | $1.5B | $1.5B |
| Revenue growth | 237.5% | — | — | 18.5% | −2.8% |
| Net interest income | −$2.5M | — | −$16.0M | −$22.2M | −$55.0M |
| Operating margin | −5.8% | — | −13.3% | −21.4% | −18.5% |
| Net income | −$31.4M | — | −$57.8M | −$136M | −$148M |
| Net margin | −6.4% | — | −4.6% | −9.1% | −10.1% |
| Diluted EPS | — | — | −$0.63 | −$54.06 | −$45.26 |
| Cash | |||||
| Cash from operations | −$24.6M | — | −$76.0M | −$110M | −$91.2M |
| Capital expenditure | $2.9M | — | $1.8M | $0.0M | — |
| Free cash flow | −$27.5M | — | −$77.9M | −$110M | — |
| FCF margin | −5.6% | — | −6.1% | −7.3% | — |
| Share count change | — | — | — | −99.0% | 11.2% |
| Debt and strength | |||||
| Cash and short-term investments | $36.3M | $17.5M | $36.3M | $38.8M | $25.0M |
| Debt incl. finance leases | $55.1M | $94.4M | $108M | $109M | $273M |
| Shareholders' equity | $0.0M | $5.9M | $142M | $75.9M | −$155M |
| Current ratio | 1.0x | 0.4x | 0.6x | 0.4x | 0.2x |
| Returns and quality | |||||
| Return on capital | −119.5% | — | −62.0% | −173.5% | −229.2% |
| Return on equity | −138,376.7% | — | −78.1% | −124.6% | — |
| Piotroski F-score | — | — | — | 3 | 2 |
| Altman Z'' | −5.8 | — | −3.4 | −7.3 | −10.3 |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$0.8M
1 insider
Of sales under plans
0%
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
P3 Health Partners Inc. · PIII
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $4.14 a share, the company is worth $13.9M.
Source: SEC EDGAR XBRL filings (CIK 0001832511). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.